B. Braun, which owns shares in Germany-based hospital operator Rhoen-Klinikum is upping its stake in Rhoen to 25 percent in efforts to prevent a buyout of Rhoen by B. Braun rival Fresenius.
The move closely follows last year’s efforts, which saw B. Braun acquire five percent in Rhoen to prevent Fresenius’s agenda of becoming the nation’s largest private hospital operator. B. Braun and Fresenius are rivals in the healthcare equipment market.
Both B. Braun and hospital operator Asklepios – which also holds shares in Rhoen – were reportedly concerned that a buyout by Fresenius would reduce competition in the market. In a statement released Tuesday, B. Braun said it “remains committed to sustainably secure the minority shareholding position” in Rhoen.
The acquisition remains subject to regulatory approval.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Google and South Carolina Clash Over State Records Demand
May 8, 2024 by
CPI
Telefonica Germany Teams Up with Amazon Web Services to Migrate 5G Customers
May 8, 2024 by
CPI
Federal Judge Grants $7.4 Million Settlement in Pork Price-Fixing Case
May 8, 2024 by
CPI
Wilson Sonsini Bolsters Antitrust and Competition Practice with Key Partner Returns
May 8, 2024 by
CPI
EU to Scrutinize Telecom Italia’s Network Sale to KKR
May 8, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI